Confronting Parallel Trade in Life Sciences: Challenges and Strategies to Mitigate Its Impact

Parallel trade is disrupting the pharmaceutical and medical device industries, creating revenue loss, supply chain instability, and elevated risks to quality and reputation. Regulatory frameworks, price differentials, and market dynamics have fueled this

But you don’t have to stand by—take charge with smarter pricing and supply chain strategies!

When your Gross-to-Net process lacks clarity, strategic decisions become a challenge. Whether you're managing commercial incentives, mandatory adjustments, or complex outcome-based agreements, every financial and commercial decision impacts your bottom line. 

Join us for a 30-minute session where you’ll discover:

• The real impact of parallel trade on revenue, supply chain and market stability
• How data-driven insights can reduce revenue leakage and strengthen pricing strategies
• Smart pricing tactics like conditional pricing and demand-based controls
• Real-world case studies from leading life sciences companies